Research Article
Superficial Morphea: Clinicopathological Characteristics and a Novel Therapeutic Outcome to Excimer Light Therapy
Table 1
Comparison between demographic data and clinical features in superficial morphea and localized scleroderma.
| | Demographic and clinical data | Superficial morphea (n = 28) | Localized scleroderma (n = 46) |
| | Age | | | | Range | 26–47 | 19–61 | | Mean ± SD | 33 ± 2.11 | 45 ± 8.7 |
| | Sex | | | | Male | 8 (28.6%) | 19 (41.3%) | | Female | 20 (71.4%) | 27 (58.7%) | | M/F ratio | 1 : 2.5 | 1 : 1.4 |
| | Duration of the disease (m) | | | | Range | 7–22 | 4–13 | | Mean ± SD | 15 ± 3.56 | 8 ± 3.82 |
| | Clinical features of the lesion (s) | | | | Number (single/multiple) | 7 (25%)/21 (75%) | 24 (52.2%)/22 (47.8%) | | Border (well defined/ill-defined) | 3 (10.7%)/25 (89.3%) | 10 (21.7%)/36 (78.3%) | | Size (small <5 cm/large >5 cm) | 5 (17.9%)/23 (82.1%) | 11 (23.9%)/35 (76.1%) | | Induration (no/mild/moderate) | 11 (39.3%)/17 (60.7%)/0 | 0/5 (10.9%)/41 (89.1%) | | Location (trunk/upper limb/lower limb/disseminated) | 18 (64.3%)/2 (7.1%)/7 (25%)/1(3.6%) | 11 (23.9%)/13 (28.3%)/15 (32.6%)/19 (41.3%) |
| | Associated diseases | | | | Diabetes mellitus | 14 (50%) | 20 (43.5%) | | Hypertension | 6 (21.4%) | 8 (17.4%) | | Hepatitis C virus infection | 12 (42.8%) | 10 (21.7%) | | Chronic renal disease | 4 (14.3%) | 6 (13%) | | Other connective tissue disease | 1 (3.6%) | 7 (15.2%) | | Total (positive association) | 24 (85.7%) | 37 (80.4%) |
|
|
